XAIR (Beyond Air) Moat Score: 4/10 (As of Jul. 03, 2026)


XAIR Beyond Air Inc XAIR
25 GF Score
Price $0.46
GF Value $6.78
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Beyond Air Moat Score?

Beyond Air XAIR +1.19% 25 Moat Score is 4 as of Jul. 03, 2026. GuruFocus rates XAIR with a GF Score™ of 25/100 and a GF Value™ of $6.78 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 845 Medical Devices & Instruments companies, Beyond Air ranks better than 83.31% on this metric.

Beyond Air has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Beyond Air has Narrow Moat: Beyond Air has valuable intellectual property in medical technology and some regulatory barriers. However, its market share is modest, and it lacks strong brand strength or network effects, resulting in a discernible but modest moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Beyond Air might have Narrow Moat - Discernible but modest moat.

Beyond Air  (NAS:XAIR) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Beyond Air Moat Score Related Terms

XAIR vs VVOS, TNON, BMRA: Moat Score Comparison

For the Medical Devices subindustry, Beyond Air's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beyond Air Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Moat Score distribution charts can be found below:

* The bar in red indicates where Beyond Air's Moat Score falls into.


XAIR
25GF Score
Beyond Air Inc XAIR
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Beyond Air (XAIR) has a Moat Score of 4 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Beyond Air ranks #141 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Beyond Air's Moat Score too high?
Beyond Air's current Moat Score is 4. Based on the distribution chart, Beyond Air ranks #141 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Beyond Air has a GF Score™ of 25/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beyond Air's Moat Score compare to VVOS and TNON?
According to the Medical Devices & Instruments industry distribution chart, Beyond Air ranks #141 out of 845 companies for Moat Score. This places Beyond Air in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Beyond Air's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beyond Air stock overvalued right now?
Based on GuruFocus' analysis, Beyond Air (XAIR) is currently considered Possible Value Trap. The stock's GF Value™ is $6.78, compared to a current price of $0.46 — trading 93.2% below its estimated fair value. The current Moat Score is 4. Beyond Air's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Beyond Air (XAIR), the current Moat Score is 4 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beyond Air (XAIR) Overvalued in 2026?

Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued. The current stock price of $0.46 is trading 93.2% below its estimated GF Value™ of $6.78. GuruFocus considers Beyond Air to be Possible Value Trap.

Key valuation signals for XAIR:

  • Moat Score: 4
  • GF Value™: $6.78 vs. price of $0.46 (93.2% below fair value)
  • GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the XAIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beyond Air Business Description

Address 900 Stewart Avenue, Suite 301, Garden City, New York, NY, USA, 11530
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
25GF Score

Get the complete analysis for XAIR

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.46
Price
$6.78
GF Value